Cambridge Investment Research Advisors’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.6M Sell
30,386
-7,371
-20% -$2.12M 0.02% 749
2026
Q1
$11.9M Buy
37,757
+3,705
+11% +$1.29M 0.03% 553
2025
Q4
$11.5M Sell
34,052
-12,899
-27% -$4.4M 0.03% 530
2025
Q3
$14.7M Buy
46,951
+2,022
+5% +$595K 0.04% 445
2025
Q2
$13.5M Buy
44,929
+7,696
+21% +$2.22M 0.04% 441
2025
Q1
$10.4M Sell
37,233
-9,988
-21% -$2.51M 0.03% 495
2024
Q4
$10.6M Buy
47,221
+6,570
+16% +$1.55M 0.04% 467
2024
Q3
$9.15M Sell
40,651
-14,997
-27% -$3.48M 0.03% 541
2024
Q2
$12.5M Buy
55,648
+22,013
+65% +$5.1M 0.05% 395
2024
Q1
$8.17M Sell
33,635
-14,955
-31% -$3.44M 0.03% 530
2023
Q4
$9.98M Buy
48,590
+839
+2% +$164K 0.04% 410
2023
Q3
$8.59M Buy
47,751
+12,510
+35% +$2.31M 0.04% 429
2023
Q2
$6.78M Buy
35,241
+35
+0.1% +$6.06K 0.03% 519
2023
Q1
$5.64M Sell
35,206
-36,869
-51% -$5.85M 0.03% 578
2022
Q4
$11.9M Buy
72,075
+38,652
+116% +$6.11M 0.06% 314
2022
Q3
$4.52M Buy
33,423
+4,027
+14% +$578K 0.03% 618
2022
Q2
$4.16M Buy
29,396
+290
+1% +$44.4K 0.02% 667
2022
Q1
$4.5M Sell
29,106
-695
-2% -$98.4K 0.02% 680
2021
Q4
$3.96M Buy
29,801
+2,310
+8% +$284K 0.02% 761
2021
Q3
$3.28M Sell
27,491
-9,929
-27% -$1.19M 0.02% 822
2021
Q2
$4.28M Sell
37,420
-541
-1% -$63.9K 0.02% 701
2021
Q1
$4.48M Sell
37,961
-462
-1% -$50K 0.02% 607
2020
Q4
$3.76M Sell
38,423
-4,747
-11% -$475K 0.02% 625
2020
Q3
$4.18M Buy
43,170
+4,675
+12% +$465K 0.03% 522
2020
Q2
$3.88M Sell
38,495
-1,933
-5% -$178K 0.03% 520
2020
Q1
$3.58M Buy
40,428
+2,464
+6% +$217K 0.03% 473
2019
Q4
$3.23M Buy
37,964
+4,650
+14% +$398K 0.02% 609
2019
Q3
$2.74M Buy
33,314
+2,672
+9% +$230K 0.02% 630
2019
Q2
$2.61M Sell
30,642
-474
-2% -$37.5K 0.02% 617
2019
Q1
$2.47M Buy
31,116
+304
+1% +$24.4K 0.02% 633
2018
Q4
$2.29M Sell
30,812
-4,581
-13% -$395K 0.03% 586
2018
Q3
$3.26M Buy
35,393
+823
+2% +$71.2K 0.03% 497
2018
Q2
$2.95M Sell
34,570
-2,052
-6% -$180K 0.03% 508
2018
Q1
$3.16M Buy
36,622
+1,401
+4% +$135K 0.04% 470
2017
Q4
$3.23M Sell
35,221
-3,376
-9% -$279K 0.04% 427
2017
Q3
$3.19M Buy
38,597
+2,647
+7% +$225K 0.04% 392
2017
Q2
$3.4M Buy
+35,950
New +$3.2M 0.05% 344
2016
Q4
Sell
-30,945
Closed -$2.5M 1732
2016
Q3
$2.5M Buy
+30,945
New +$2.65M 0.05% 365
2016
Q2
Sell
-6,764
Closed -$585K 1616
2016
Q1
$585K Sell
6,764
-2,318
-26% -$207K 0.01% 817
2015
Q4
$942K Buy
+9,082
New +$892K 0.02% 571
2015
Q3
Sell
-6,396
Closed -$680K 1501
2015
Q2
$680K Buy
6,396
+1,875
+41% +$211K 0.02% 664
2015
Q1
$514K Buy
4,521
+113
+3% +$11.4K 0.01% 784
2014
Q4
$397K Sell
4,408
-23
-0.5% -$1.97K 0.01% 884
2014
Q3
$342K Buy
4,431
+257
+6% +$19.5K 0.01% 1024
2014
Q2
$303K Sell
4,174
-196
-4% -$13.4K 0.01% 1004
2014
Q1
$287K Sell
4,370
-285
-6% -$19.4K 0.01% 983
2013
Q4
$327K Buy
4,655
+114
+3% +$7.66K 0.01% 837
2013
Q3
$277K Buy
4,541
+83
+2% +$4.85K 0.01% 875
2013
Q2
$249K Buy
+4,458
New +$242K 0.01% 840

Other funds holding COR

Cambridge Investment Research Advisors's COR Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Cencora (COR) stake by 20% in Q2 2026, selling an estimated $2.12M and leaving 30,386 shares worth $8.6M. The position accounts for 0.02% of the portfolio, ranked #749.

Cambridge Investment Research Advisors first reported a position in COR in Q2 2013 and has held it in 49 quarters since. The position peaked at $14.7M in Q3 2025. 1,343 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • Cambridge Investment Research Advisors held 30,386 shares of Cencora worth $8.6M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 7,371 Cencora shares in Q2 2026, an estimated $2.12M.
  • Cencora made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #749 holding.
  • Cambridge Investment Research Advisors first reported a position in Cencora in Q2 2013 and has held it in 49 quarters since.
  • Cambridge Investment Research Advisors's Cencora position peaked at $14.7M in Q3 2025.
  • 1,343 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.